X-ray absorption fine structure analysis of the local environment of zinc in dentine treated with zinc compounds.
It has been reported that zinc oxide (ZnO) inhibits dentine demineralization. By using the X-ray absorption fine structure (XAFS) technique, our aims in this study were to provide information about the local environment of zinc atoms in dentine that had been treated with zinc compounds. We measured the Zn K-edge X-ray absorption near-edge structure (XANES) and the extended X-ray absorption fine structure (EXAFS) of dentine specimens treated with zinc chloride or ZnO. In XAFS analyses, the spectra of dentine specimens treated with ZnO (D-ZO) or with zinc chloride (D-ZC) were similar and obviously different from the reference ZnO spectrum. This suggests that most of the zinc atoms detected in D-ZO are not derived from particles of ZnO. The spectra of D-ZO and D-ZC were similar to the spectrum of the synthetic, zinc-containing hydroxyapatite, but were not similar to that of zinc in ZnCl2-treated collagen. The results of this study suggest that most of the zinc atoms detected were attached to hydroxyapatite and not to collagen.
Takatsuka
Tsutomu
T
R & D Department, SUNSTAR Inc., Kamihamuro Takatsuki, Osaka, Japan. tsutomu.takatsuka@sunstar.com
Hirano
Junko
J
Matsumoto
Hitoshi
H
Honma
Tetsuo
T
D000818:Animals; D002417:Cattle; D002712:Chlorides / Q000493:pharmacokinetics; D003094:Collagen / Q000737:chemistry; D003743:Dental Enamel / Q000737:chemistry / Q000378:metabolism; D003804:Dentin / Q000737:chemistry / Q000378:metabolism*; D017886:Durapatite / Q000737:chemistry; D013057:Spectrum Analysis; D014965:X-Rays; D015032:Zinc / Q000032:analysis*; D017967:Zinc Compounds / Q000493:pharmacokinetics*; D015034:Zinc Oxide / Q000493:pharmacokinetics
D002712:Chlorides; D017967:Zinc Compounds; C016837:zinc chloride; D003094:Collagen; D017886:Durapatite; D015032:Zinc; D015034:Zinc Oxide